Certified Advisory Corp’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.1M Sell
42,418
-89,251
-68% -$4.53M 0.17% 120
2026
Q1
$7.02M Sell
131,669
-5,214
-4% -$306K 0.63% 49
2025
Q4
$8.51M Sell
136,883
-891
-0.6% -$55K 0.78% 40
2025
Q3
$8.28M Buy
137,774
+5,438
+4% +$333K 0.79% 41
2025
Q2
$8.29M Sell
132,336
-2,286
-2% -$137K 0.86% 36
2025
Q1
$8.1M Sell
134,622
-1,750
-1% -$109K 0.92% 35
2024
Q4
$7.96M Sell
136,372
-2,285
-2% -$136K 0.86% 36
2024
Q3
$8.21M Sell
138,657
-2,251
-2% -$129K 0.91% 36
2024
Q2
$7.9M Buy
140,908
+287
+0.2% +$16.1K 0.99% 28
2024
Q1
$8.24M Buy
140,621
+3,319
+2% +$187K 1.15% 20
2023
Q4
$7.41M Sell
137,302
-716
-0.5% -$35K 1.12% 21
2023
Q3
$6.69M Buy
138,018
+583
+0.4% +$31K 1.23% 19
2023
Q2
$7.76M Sell
137,435
-765
-0.6% -$42.1K 1.43% 14
2023
Q1
$7.46M Buy
138,200
+22,092
+19% +$1.18M 1.33% 18
2022
Q4
$6.1M Buy
116,108
+3,661
+3% +$186K 1.21% 20
2022
Q3
$5.3M Buy
112,447
+2,478
+2% +$129K 1.21% 18
2022
Q2
$5.55M Buy
109,969
+9,012
+9% +$491K 1.24% 22
2022
Q1
$6.15M Buy
100,957
+10,402
+11% +$620K 1.31% 16
2021
Q4
$5.96M Buy
90,555
+6,037
+7% +$386K 1.32% 15
2021
Q3
$5.31M Buy
84,518
+20,426
+32% +$1.3M 1.29% 17
2021
Q2
$3.86M Buy
64,092
+12,798
+25% +$740K 0.97% 25
2021
Q1
$2.82M Buy
+51,294
New +$2.84M 0.73% 34
2020
Q2
$546K Buy
12,378
+10,206
+470% +$436K 0.18% 117
2020
Q1
$82K Buy
2,172
+1,386
+176% +$58.4K 0.03% 228
2019
Q4
$35K Hold
786
0.01% 369
2019
Q3
$32K Buy
+786
New +$32.2K 0.01% 386

Other funds holding IHI

Certified Advisory Corp's IHI Position: Q2 2026 in Review

Certified Advisory Corp reduced its iShares US Medical Devices ETF (IHI) stake by 68% in Q2 2026, selling an estimated $4.53M and leaving 42,418 shares worth $2.1M. The position accounts for 0.17% of the portfolio, ranked #120.

Certified Advisory Corp first reported a position in IHI in Q3 2019 and has held it in 26 quarters since. The position peaked at $8.51M in Q4 2025. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • Certified Advisory Corp held 42,418 shares of iShares US Medical Devices ETF worth $2.1M as of Q2 2026.
  • Certified Advisory Corp sold 89,251 iShares US Medical Devices ETF shares in Q2 2026, an estimated $4.53M.
  • iShares US Medical Devices ETF made up 0.17% of Certified Advisory Corp's portfolio in Q2 2026, its #120 holding.
  • Certified Advisory Corp first reported a position in iShares US Medical Devices ETF in Q3 2019 and has held it in 26 quarters since.
  • Certified Advisory Corp's iShares US Medical Devices ETF position peaked at $8.51M in Q4 2025.
  • 501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Certified Advisory Corp's 13F filing for Q2 2026, filed 16 Jul 2026.